Renal denervation is an exciting new treatment for patients with drug-resistant high blood pressure.
Renal denervation has been shown , in a randomised trial published in The Lancet, to reduce blood pressure by 32mmHg in patients with systolic blood pressures greater than 160mmHg. despite three drugs.
This effect appears to be long-lasting, though with such a new technology, more work is ongoing to better understand long-term outcomes.
There have now been more than 6000 cases performed worldwide with few complications.
Currently, the technology is only recommended for patients whose systolic blood pressure (the top number) is greater than 160mmHg despite three blood pressure medications.
This technology is delivered by a team of specialists based in Exeter, including cardiologists from Exeter Heart, working with kidney and interventional radiology specialists from Exeter. Any suitable Exeter Heart patients who wish to be treated with this technology, will be treated by this team.